Our World
in Data
Gdoc/Admin

Influenza

By: Saloni Dattani, Fiona Spooner, Hannah Ritchie, and Max Roser

Seasonal flu is a contagious illness caused by the influenza virus. It kills an average of 700,000 people each year from respiratory disease or cardiovascular disease.1 In large pandemics, when new strains have evolved, the death toll has been much higher.

Yet, data on the flu is limited. With better testing, countries could improve their response to flu epidemics. It could help to rapidly identify new strains, detect epidemics early, and design better-matched vaccines to target flu strains circulating in the population.

This page therefore shows estimates of deaths during seasonal flu epidemics, historical flu pandemics, patterns of flu seasons in different countries, and confirmed cases of flu and flu-like symptoms across the world.

It also includes our Flu Explorer, a resource for epidemiologists, infectious disease researchers, and public health experts to monitor the global spread of the influenza virus.

Key Insights on Influenza

Seasonal flu kills hundreds of thousands of people worldwide each year

In serious cases, the flu can lead to health complications such as pneumonia, strokes, and heart attacks, which can be deadly.

In total, researchers estimate that the flu causes 400,000 respiratory deaths and 300,000 cardiovascular deaths each year.1

The flu is most severe in infants and the elderly.2

Among those over 65, the flu kills around 31 people per 100,000 each year from respiratory disease in Europe. You can see this on the map.

But it’s not only age that matters, as the map shows. Death rates from the flu are higher in countries in South America, Africa, and South Asia than in Europe and North America, due to poverty, poorer underlying health, lower access to healthcare, and lower vaccination rates.

In this article, we cover this in more detail:

How many people die from the flu?

The risk of death from influenza has declined over time, but globally, hundreds of thousands of people still die from the disease each year.

What you should know about this data
  • The annual mortality rate of influenza was estimated by the Global Pandemic Mortality Project II using data between 2002 and 2011.3 They made these estimates using data from routine surveillance metrics for the flu, along with the number of excess deaths that occurred during flu seasons and mortality records where deceased people had respiratory symptoms.
  • These are estimates of flu deaths due to respiratory symptoms. People also die from other complications of the flu — such as a stroke or heart attack — which are not shown on the map.
  • Estimates in low-income countries tend to be less certain due to lower levels of testing for influenza and limited mortality records.

Social distancing during COVID-19 had a large impact on the flu

In many countries, flu became much rarer during the COVID-19 pandemic, due to the impact of social distancing.

You can see this in the chart. It shows the share of flu tests that were positive. In 2020 and 2021, there was a large decline in flu and the rates of positive tests were low.

Because the influenza virus is spread between people, through respiratory droplets and human contact4, social distancing led to a large reduction in contact between people and limited the virus from spreading.5

This decline was very large because of the mathematics of epidemics.

The reproductive number (also called the R number) can help to understand why. This refers to the average number of people who will be infected by someone with the virus. When the R number is greater than 1, the average person who is infected will spread the virus to more than one person, who spread it to more and more people; the number of cases rises exponentially and leads to an epidemic.6

However, when the R number is lower than 1, the virus does not lead to an epidemic, and the number of cases falls exponentially.

Seasonal flu viruses tend to have an R number that is slightly above 1 at the start of an epidemic.7 Social distancing cut the number of contacts between people, and led to the R number of flu to dip much below 1 for a long time. This is why the spread of flu dwindled worldwide and was only seen in limited circumstances.8

What you should know about this data
  • Testing to confirm flu is limited in many countries.9 We therefore show the share of tests that were positive for the influenza virus.

Seasonal flu used to be far more deadly

Over time, the severity of the flu has declined among people of the same age, as the chart shows.10

This is because of flu vaccination, which began in the 1930s and 1940s, as well as improvements in sanitation, neonatal healthcare, and childhood vaccination for other diseases.11 These benefits carried forward as people aged: they protected people from being vulnerable to diseases including influenza.

But the flu still causes a large burden today, especially in countries that have poor sanitation, healthcare, and low vaccination rates.

Another challenge is that populations have been aging rapidly.10 In lower-income countries, the flu could become a larger burden as their populations continue to age.

In this article, we cover this in more detail:

How many people die from the flu?

The risk of death from influenza has declined over time, but globally, hundreds of thousands of people still die from the disease each year.

What you should know about this data
  • These estimates come from a study by Enrique Acosta and colleagues, using data from the United States.10
  • The authors use national data on deaths and routine surveillance data for flu to calculate the rate of excess deaths during flu seasons, while accounting for changes in the age structure of the population.
  • The chart shows that the risk that someone dies from influenza at a given age has declined over time. But, because the population is getting larger and older, the total number of flu deaths has remained stable.
alt: People born more recently have a lower risk of dying from influenza. Even when they reached the same age, people born in 1940 had a third of the risk of dying from flu than those born in 1900. This risk halved further for those born in 1980.

Flu seasons vary between countries

Several respiratory infections, including the flu, are more common in the winter.

This is because they transmit more efficiently at lower temperatures and humidity, and when there is more social contact between people indoors.12

In the chart, you can see the share of flu tests that were positive in different countries.

Although the precise start and end of a flu season vary between years, flu epidemics tend to occur between November and May in the Northern Hemisphere. Meanwhile, in the Southern Hemisphere, they generally occur between June and October.

But in countries closer to the equator, there tend to be multiple peaks each year, or flu is present throughout the year. This may be because of rainy seasons, when people have more indoor contact.13

You can see this in the chart for Singapore and Thailand, for example.

What you should know about this data
  • Testing to confirm the flu is limited in many countries.9

Tracking flu-like symptoms can be informative when testing is limited

Direct testing for the presence of the influenza virus is limited in many countries. For this reason, flu cases recorded in public databases – and the global data shown in our data explorer – greatly underestimate the true number of cases.

Because of the lack of direct testing, it is useful to track flu-like symptoms.

It is important to note however that these symptoms are not specific to the flu: people with other diseases – such as rhinovirus, COVID-19, common colds, malaria, and others – can also have these symptoms and meet the following criteria.

Acute respiratory infections (ARIs) are the broadest type of metric. They can include anyone with sudden onset of at least one of the following symptoms: cough, sore throat, shortness of breath or rhinitis (inflammation of the mucous lining of the nose), but only if they were judged by a doctor to be caused by an infection.

Influenza-like illnesses (ILIs) are narrower – they include only people with a sudden respiratory infection with a fever above 38ºC and a cough within the last 10 days.14

Severe acute respiratory infections (SARIs) are severe cases of ILIs: they include only people with a sudden respiratory infection who had a fever above 38ºC, a cough, and required hospitalization.

In many countries, only a fraction of clinics in the country report flu-like metrics to their national system. This means that the number of reported cases does not tell us about the total number of people with these infections.

Since some countries provide data from a larger number of healthcare clinics than others, this needs to be kept in mind when comparing different countries.15

What you should know about this data
  • Countries may use different sources for each metric. Some countries collect data for ARIs universally, i.e. from all hospitals and outpatient clinics in the country, while many do not.16
  • The country's sampling method may also be different for ILIs or SARIs. The sampling strategy for each metric and for each country is reported to the WHO.17

Different flu strains circulate each year

Each year, flu vaccines need to be updated because different viruses circulate in the population.

This happens for two reasons. One is that flu viruses gradually evolve, and can evade people’s immunity and cause reinfections.18

Another reason is that there are different types of flu that circulate each season.

You can see this in the chart. It shows cases of two types of influenza: A and B, which commonly infect humans.19

There are many subtypes of influenza A, including H1N1 and H3N2 among others.20 In contrast, there are two lineages of influenza B, which are called Victoria and Yamagata.21

Unfortunately, testing for the flu is limited, and many countries lack testing to identify specific flu strains. This is why the number of confirmed cases shown in the chart greatly underestimates the actual number of infections, and why some cases are shown as ‘unknown subtype/lineage’.22

This lack of testing is a problem. When there is a mismatch between the strains in the vaccine and the viruses circulating in the population, vaccines tend to have lower efficacy and the flu season tends to be more severe.23 Additionally, limited testing also means the world is less able to detect new strains that may cause pandemics.24

To address this, the world needs more routine testing for the flu.

What you should know about this data
  • This metric shows confirmed cases of flu: when people with flu symptoms have respiratory samples taken and tested to determine whether they have the influenza virus and whether they have influenza A or B. Some surveillance centers also test the samples to identify their subtype. These are described as strains for influenza A (e.g., A H7N9) and lineages for influenza B (e.g., B Yamagata). This testing can use molecular detection, virus culture, or immunological methods.25
  • Testing to confirm flu is limited in many countries.9 In addition, not all confirmed flu cases are tested further to identify their strain. This is why many cases are shown as having an unknown subtype or lineage.26

The Spanish flu caused the largest influenza pandemic in history

Some flu seasons are far more severe than usual seasonal influenza.

This happens when influenza viruses combine with each other to make new strains which are more infectious and lethal, and lead to deadly pandemics.18

For example, the Spanish flu pandemic was caused by a combination of human influenza and another animal influenza. Together, they formed the new H1N1 virus.27

As you can see in the chart, it led to the most devastating influenza pandemic in recorded history. Estimates of the death toll vary: some studies estimate that 17.4 million people died globally from the Spanish flu between 1918 and 1920, while others estimate a much higher death toll of 50 to 100 million deaths.28

The Spanish flu pandemic was most severe among children and young adults. Life expectancy at birth and at young ages declined by more than ten years.

But surprisingly, it did not have a significant impact on older people. Research suggests that this is because older generations had been exposed to similar H1 influenza viruses decades before the pandemic began, which gave them some protection against the Spanish flu strain.29

In this article, we cover this in more detail:

The Spanish flu: The global impact of the largest influenza pandemic in history

What you should know about this data
  • In the chart, we show a comparison of mortality estimates from different research groups for recent flu pandemics in history.30
  • Estimates for historical flu pandemics tend to come from data on mortality rates. Pandemics cause sudden shocks to mortality compared to typical years. Researchers can calculate the excess mortality during the pandemic to estimate the deaths they caused while adjusting for other known factors, such as famine and war.
  • There are still large uncertainties in each estimate, because historical mortality records are limited in many countries. However, the range of estimates for these pandemics is much higher than a typical flu season. For the Spanish flu pandemic, estimates are more than an order of magnitude higher.
Bar chart comparing estimated death tolls for a range of flu pandemics.

Explore our data on influenza

Why we provide this Influenza Data Explorer

With this Flu Explorer, we aim to provide a helpful resource for epidemiologists, infectious disease researchers, and public health experts to understand the global spread of the influenza virus.

It differs from our widely-used infectious diseases projects, such as the COVID-19 Explorer and the Mpox Explorer. These tools are designed for a broad audience. Unfortunately, flu data is incomplete in many ways, making it harder to communicate. This tool is therefore designed for users with pre-existing knowledge to navigate effectively the complex data published by the World Health Organization.

The explorer also highlights the significant gaps in influenza data. It is an important reminder of the need to improve data collection and reporting.

Research & Writing

How many people die from the flu?

Saloni Dattani and Fiona Spooner

The Spanish flu: The global impact of the largest influenza pandemic in history

Max Roser

Key Charts on Influenza

See all charts on this topic
Availability of flu vaccines
Chart 1 of 6

Endnotes

  1. It’s estimated that seasonal influenza kills around 400,000 globally from respiratory disease (Paget et al., 2019), and 300,000 from cardiovascular disease (Chaves et al., 2023).

    These estimates relate to mutually exclusive figures, as they are based on the proportion of deaths listed as caused by respiratory disease and cardiovascular diseases respectively that are attributable to influenza.

    Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, Simonsen L, Viboud C; Global Seasonal Influenza-associated Mortality Collaborator Network and GLaMOR Collaborating Teams*. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J Glob Health. 2019 Dec;9(2):020421. doi: 10.7189/jogh.09.020421. https://jogh.org/documents/issue201902/jogh-09-020421.pdf

    Chaves, S. S., Nealon, J., Burkart, K. G., Modin, D., Biering-Sørensen, T., Ortiz, J. R., Vilchis-Tella, V. M., Wallace, L. E., Roth, G., Mahe, C., & Brauer, M. (2023). Global, regional and national estimates of influenza-attributable ischemic heart disease mortality. eClinicalMedicine, 55, 101740. https://doi.org/10.1016/j.eclinm.2022.101740

    See also -

    In recent meta-analyses, Behrouzi et al. found that influenza vaccination reduces the chances of major cardiovascular events (such as heart attacks and strokes) by around 34%, in clinical trials of the elderly.

    Behrouzi, B., Bhatt, D. L., Cannon, C. P., Vardeny, O., Lee, D. S., Solomon, S. D., & Udell, J. A. (2022). Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis. JAMA Network Open, 5(4), e228873.

  2. Metcalf, C. J. E., Paireau, J., O’Driscoll, M., Pivette, M., Hubert, B., Pontais, I., Nickbakhsh, S., Cummings, D. A. T., Cauchemez, S., & Salje, H. (2022). Comparing the age and sex trajectories of SARS-CoV-2 morbidity and mortality with other respiratory pathogens. Royal Society Open Science, 9(6), 211498.

  3. Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, Simonsen L, Viboud C; Global Seasonal Influenza-associated Mortality Collaborator Network and GLaMOR Collaborating Teams*. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J Glob Health. 2019 Dec;9(2):020421. doi: 10.7189/jogh.09.020421.

  4. Kutter, J. S., Spronken, M. I., Fraaij, P. L., Fouchier, R. A., & Herfst, S. (2018). Transmission routes of respiratory viruses among humans. Current Opinion in Virology, 28, 142–151. https://doi.org/10.1016/j.coviro.2018.01.001

  5. Farboodi, M., Jarosch, G., & Shimer, R. (2021). Internal and external effects of social distancing in a pandemic. Journal of Economic Theory, 196, 105293.

    Woskie, L. R., Hennessy, J., Espinosa, V., Tsai, T. C., Vispute, S., Jacobson, B. H., Cattuto, C., Gauvin, L., Tizzoni, M., Fabrikant, A., Gadepalli, K., Boulanger, A., Pearce, A., Kamath, C., Schlosberg, A., Stanton, C., Bavadekar, S., Abueg, M., Hogue, M., … Gabrilovich, E. (2021). Early social distancing policies in Europe, changes in mobility & COVID-19 case trajectories: Insights from Spring 2020. PLOS ONE, 16(6), e0253071.

  6. Rothman, K. J., Lash, T. L., VanderWeele, T. J., & Haneuse, S. (2021). Modern epidemiology (Fourth edition). Wolters Kluwer.

  7. ​​Biggerstaff, M., Cauchemez, S., Reed, C., Gambhir, M., & Finelli, L. (2014). Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: A systematic review of the literature. BMC Infectious Diseases, 14(1), 480.

  8. This effect was so large that it may have led to the extinction of a lineage of flu called influenza B Yamagata.

    Dhanasekaran, V., Sullivan, S., Edwards, K. M., Xie, R., Khvorov, A., Valkenburg, S. A., Cowling, B. J., & Barr, I. G. (2022). Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nature Communications, 13(1), 1721.

    Paget, J., Caini, S., Del Riccio, M., van Waarden, W., & Meijer, A. (2022). Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines? Eurosurveillance, 27(39).

  9. World Health Organization & others. (2019). Global influenza strategy 2019-2030.

  10. Acosta, E., Hallman, S. A., Dillon, L. Y., Ouellette, N., Bourbeau, R., Herring, D. A., Inwood, K., Earn, D. J. D., Madrenas, J., Miller, M. S., & Gagnon, A. (2019). Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959–2016. Demography, 56(5), 1723–1746.

  11. Barberis, I., Myles, P., Ault, S. K., Bragazzi, N. L., & Martini, M. (2016). History and evolution of influenza control through vaccination: From the first monovalent vaccine to universal vaccines. Journal of Preventive Medicine and Hygiene, 57(3), E115–E120.

    Centers for Disease Control and Prevention, & National Center for Immunization and Respiratory Diseases. (2021). Historical Reference of Seasonal Influenza Vaccine Doses Distributed.

  12. Petrova, V. N., & Russell, C. A. (2018). The evolution of seasonal influenza viruses. Nature Reviews Microbiology, 16(1), 47–60.

  13. Chen, C., Jiang, D., Yan, D., Pi, L., Zhang, X., Du, Y., Liu, X., Yang, M., Zhou, Y., Ding, C., Lan, L., & Yang, S. (2023). The global region-specific epidemiologic characteristics of influenza: World Health Organization FluNet data from 1996 to 2021. International Journal of Infectious Diseases, 129, 118–124.

    Petrova, V. N., & Russell, C. A. (2018). The evolution of seasonal influenza viruses. Nature Reviews Microbiology, 16(1), 47–60.

    Paynter, S. (2015). Humidity and respiratory virus transmission in tropical and temperate settings. Epidemiology & Infection, 143(6), 1110–1118.

    Igboh, L. S., Roguski, K., Marcenac, P., Emukule, G. O., Charles, M. D., Tempia, S., Herring, B., Vandemaele, K., Moen, A., Olsen, S. J., Wentworth, D. E., Kondor, R., Mott, J. A., Hirve, S., Bresee, J. S., Mangtani, P., Nguipdop-Djomo, P., & Azziz-Baumgartner, E. (2023). Timing of seasonal influenza epidemics for 25 countries in Africa during 2010–19: A retrospective analysis. The Lancet Global Health, 11(5), e729–e739.

    ​​Newman, L. P., Bhat, N., Fleming, J. A., & Neuzil, K. M. (2018). Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016. PLOS ONE, 13(2), e0193263.

  14. This definition has been used since 2011, after the Swine flu pandemic. Since then, most countries, but not all, have adopted it.

    Fitzner, J., Qasmieh, S., Mounts, A. W., Alexander, B., Besselaar, T., Briand, S., Brown, C., Clark, S., Dueger, E., Gross, D., Hauge, S., Hirve, S., Jorgensen, P., Katz, M. A., Mafi, A., Malik, M., McCarron, M., Meerhoff, T., Mori, Y., … Vandemaele, K. (2018). Revision of clinical case definitions: Influenza-like illness and severe acute respiratory infection. Bulletin of the World Health Organization, 96(2), 122–128.

    World Health Organization. (2022). Respiratory Viruses Surveillance Country, Territory and Area Profiles, 2021.

    Simpson, R. B., Gottlieb, J., Zhou, B., Hartwick, M. A., & Naumova, E. N. (2021). Completeness of open access FluNet influenza surveillance data for Pan-America in 2005–2019. Scientific Reports, 11(1), 795.

  15. World Health Organization. (2022). Respiratory Viruses Surveillance Country, Territory and Area Profiles, 2021.

  16. For example, the United States uses the 'ILINet' system, which is connected to many clinics across the country. But, in many countries including the US, clinics participate on a voluntary basis, so not all clinics are included. Clinics in some states and demographics are less likely to be part of the system. See also: Baltrusaitis, K., Vespignani, A., Rosenfeld, R., Gray, J., Raymond, D., & Santillana, M. (2019). Differences in Regional Patterns of Influenza Activity Across Surveillance Systems in the United States: Comparative Evaluation. JMIR Public Health and Surveillance, 5(4), e13403. This means 'non-sentinel' data may not be representative of the cases across the country. They may also lack high-quality testing.

  17. World Health Organization. (2022). Respiratory Viruses Surveillance Country, Territory and Area Profiles, 2021. Simpson, R. B., Gottlieb, J., Zhou, B., Hartwick, M. A., & Naumova, E. N. (2021). Completeness of open access FluNet influenza surveillance data for Pan-America in 2005–2019. Scientific Reports, 11(1), 795.

  18. Krammer, F., Smith, G. J. D., Fouchier, R. A. M., Peiris, M., Kedzierska, K., Doherty, P. C., Palese, P., Shaw, M. L., Treanor, J., Webster, R. G., & García-Sastre, A. (2018). Influenza. Nature Reviews Disease Primers, 4(1), 3.

  19. There are four types of influenza viruses: A, B, C, and D. Influenza A and B tend to spread between people around the world each year. In contrast, influenza C and D mainly infect birds and other animals.

  20. The subtypes are named according to two proteins the virus has on its surface: hemagglutinin (H) and neuraminidase (N). There are many subtypes of each of these two proteins (18 hemagglutinin subtypes and 11 neuraminidase subtypes), but only some of the combinations have been observed. For example, H3N2 is a type of influenza A virus which has hemagglutinin subtype 3 and neuraminidase subtype 2.

    Long, J.S., Mistry, B., Haslam, S.M. et al. Host and viral determinants of influenza A virus species specificity. Nat Rev Microbiol 17, 67–81 (2019).

  21. Caini, S., Kusznierz, G., Garate, V. V., Wangchuk, S., Thapa, B., de Paula Júnior, F. J., Ferreira de Almeida, W. A., Njouom, R., Fasce, R. A., Bustos, P., Feng, L., Peng, Z., Araya, J. L., Bruno, A., de Mora, D., Barahona de Gámez, M. J., Pebody, R., Zambon, M., Higueros, R., … the Global Influenza B Study team. (2019). The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century. PLOS ONE, 14(9), e0222381.

  22. The subtype or lineage of a flu virus is not always determined during testing. This tends to be because some clinics do not test for all subtypes of influenza, due to a lack of testing resources. These are listed as unknown subtypes/lineages of influenza. For example, with influenza A, labs tend to test only whether they are the H1 or H3 strain.

    However, unknown subtypes/lineages can also include novel influenza strains, which have gone through significant evolution.

  23. Tricco, A. C., Chit, A., Soobiah, C., Hallett, D., Meier, G., Chen, M. H., Tashkandi, M., Bauch, C. T., & Loeb, M. (2013). Comparing influenza vaccine efficacy against mismatched and matched strains: A systematic review and meta-analysis. BMC Medicine, 11(1), 153.

  24. Jernigan, D. B., Lindstrom, S. . L., Johnson, J. . R., Miller, J. D., Hoelscher, M., Humes, R., Shively, R., Brammer, L., Burke, S. A., Villanueva, J. M., Balish, A., Uyeki, T., Mustaquim, D., Bishop, A., Handsfield, J. H., Astles, R., Xu, X., Klimov, A. I., Cox, N. J., & Shaw, M. W. (2011). Detecting 2009 Pandemic Influenza A (H1N1) Virus Infection: Availability of Diagnostic Testing Led to Rapid Pandemic Response. Clinical Infectious Diseases, 52(suppl_1), S36–S43.

  25. Krammer, F., Smith, G. J. D., Fouchier, R. A. M., Peiris, M., Kedzierska, K., Doherty, P. C., Palese, P., Shaw, M. L., Treanor, J., Webster, R. G., & García-Sastre, A. (2018). Influenza. Nature Reviews Disease Primers, 4(1), 3. World Health Organization & others. (2015). A manual for estimating disease burden associated with seasonal influenza.

  26. Even in participating clinics, some data can be missing. For example, data collection forms may not be filled in or reported to the WHO for all patients with influenza-like illnesses who visit the clinics. Samples may not be packaged, stored, transported, or tested correctly, especially in regions with a lack of healthcare staff and supplies. See also – World Health Organization & others. (2019). Global influenza strategy 2019-2030. Gentile, A., Paget, J., Bellei, N., Torres, J. P., Vazquez, C., Laguna-Torres, V. A., & Plotkin, S. (2019). Influenza in Latin America: A report from the Global Influenza Initiative (GII). Vaccine, 37(20), 2670–2678.

  27. Worobey, M., Han, G.-Z., & Rambaut, A. (2014). Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proceedings of the National Academy of Sciences, 111(22), 8107–8112. https://doi.org/10.1073/pnas.1324197111

  28. P. Spreeuwenberg; et al. (1 December 2018). “Reassessing the Global Mortality Burden of the 1918 Influenza Pandemic”. American Journal of Epidemiology. 187 (12): 2561–2567. doi:10.1093/aje/kwy191. PMID 30202996. Online .

  29. Gagnon, A., Miller, M. S., Hallman, S. A., Bourbeau, R., Herring, D. A., Earn, D. J. D., & Madrenas, J. (2013). Age-specific mortality during the 1918 influenza pandemic: Unravelling the mystery of high young adult mortality. PloS One, 8(8), e69586.

    Luk, J., Gross, P., & Thompson, W. W. (2001). Observations on Mortality during the 1918 Influenza Pandemic. Clinical Infectious Diseases, 33(8), 1375–1378.

    Ma, J., Dushoff, J., & Earn, D. J. D. (2011). Age-specific mortality risk from pandemic influenza. Journal of Theoretical Biology, 288, 29–34.

  30. Johnson, N. P. A. S., and Mueller, J. (2002). Updating the Accounts: Global Mortality of the 1918-1920 “Spanish” Influenza Pandemic. Bulletin of the History of Medicine, 76(1), 105–115. Patterson, K. D., & Pyle, G. F. (1991). The geography and mortality of the 1918 influenza pandemic. Bulletin of the History of Medicine, 65(1), 4–21. Spreeuwenberg, P., Kroneman, M., & Paget, J. (2018). Reassessing the Global Mortality Burden of the 1918 Influenza Pandemic. American Journal of Epidemiology, 187(12), 2561–2567. Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, Simonsen L, Viboud C; Global Seasonal Influenza-associated Mortality Collaborator Network and GLaMOR Collaborating Teams*. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J Glob Health. 2019 Dec;9(2):020421. doi: 10.7189/jogh.09.020421. Dawood, F. S., Iuliano, A. D., Reed, C., Meltzer, M. I., Shay, D. K., Cheng, P.-Y., Bandaranayake, D., Breiman, R. F., Brooks, W. A., Buchy, P., Feikin, D. R., Fowler, K. B., Gordon, A., Hien, N. T., Horby, P., Huang, Q. S., Katz, M. A., Krishnan, A., Lal, R., … Widdowson, M.-A. (2012). Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. The Lancet Infectious Diseases, 12(9), 687–695. Simonsen, L., Spreeuwenberg, P., Lustig, R., Taylor, R. J., Fleming, D. M., Kroneman, M., Van Kerkhove, M. D., Mounts, A. W., Paget, W. J., & the GLaMOR Collaborating Teams. (2013). Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study. PLoS Medicine, 10(11), e1001558.

Cite this work

Our articles and data visualizations rely on work from many different people and organizations. When citing this topic page, please also cite the underlying data sources. This topic page can be cited as:

Saloni Dattani, Fiona Spooner, Hannah Ritchie, and Max Roser (2023) - “Influenza” Published online at OurWorldinData.org. Retrieved from: '/influenza' [Online Resource]

BibTeX citation

@article{owid-influenza,
    author = {Saloni Dattani and Fiona Spooner and Hannah Ritchie and Max Roser},
    title = {Influenza},
    journal = {},
    year = {2023},
    note = {/influenza}
}
logo

Reuse this work freely

All visualizations, data, and code produced by are completely open access under the . You have the permission to use, distribute, and reproduce these in any medium, provided the source and authors are credited.

The data produced by third parties and made available by is subject to the license terms from the original third-party authors. We will always indicate the original source of the data in our documentation, so you should always check the license of any such third-party data before use and redistribution.

All of our charts can be embedded in any site.